Project Grant R21CA310158
Award Date 5/1/26
Completion Date 4/30/28
Dollars Obligated $409K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Austin, MN 55912, USA
Similar Awards
- Federal Grant Award Summary The National Cancer Institute's Cancer Treatment Research program (CFDA 93.395) awarded the Regents of the University of Michigan a $2.86 million Project Grant on September 10, 2025, with a completion date of August 31, 2029. This research initiative develops novel therapeutic strategies to combat colibactin, a carcinogenic metabolite produced by pathogenic enteric bacteria associated with colorectal cancer (CRC). The project delivers two primary products: (1) an...
- Federal Project Grant Award Summary The National Cancer Institute (NCI) awarded $119,858 to the Regents of the University of Minnesota under the Cancer Biology Research program (CFDA 93.396) on August 7, 2025, for a project extending through July 31, 2030. This project grant supports fundamental research aimed at elucidating and overcoming T cell dysfunction in pancreatic ductal adenocarcinoma (PDA), a disease notoriously resistant to immunotherapy. The research program comprises three...
- Federal Grant Award Summary The National Cancer Institute awarded a $105,189 Project Grant to the Regents of the University of Minnesota under the Cancer Research Manpower program (CFDA 93.398) effective December 1, 2025, with completion targeted for June 30, 2027. This award funds research aimed at deciphering the structural dynamics and inhibition mechanisms of APOBEC3A (A3A) and APOBEC3B (A3B) enzymes, which play dual roles in host antiviral defense and genomic stability while contributing to...
- Federal Project Grant Award Summary The National Cancer Institute awarded $395,973 to the University of Minnesota (Regents of the University of Minnesota) under the Cancer Treatment Research program (CFDA 93.395) for a project focused on developing deazaflavin analogs as selective multidrug resistance protein 1 (MRP1) inhibitors for cancer chemosensitization. The award period runs from September 5, 2025 through August 31, 2027. The project delivers research and development services aimed at...
- Federal Project Grant Award Summary Mayo Clinic received a $161,400 Project Grant award from the National Cancer Institute (NCI) under the Cancer Detection and Diagnosis Research program (CFDA 93.394) for the period August 1, 2025 through July 31, 2027. The award supports research to develop and validate innovative ferroptosis-based therapeutic approaches targeting cholangiocarcinoma (CCA), a highly lethal malignancy of the liver and biliary tract with a five-year survival rate below 10%. The...
- Federal Project Grant Award Summary The National Cancer Institute awarded $394,532 through its Cancer Treatment Research program (CFDA 93.395) to the Regents of the University of Minnesota on July 15, 2025, to support research investigating LAT1 (L-type amino acid transporter 1) as a novel therapeutic target in colorectal cancer. The research will be conducted through June 30, 2027, and focuses on developing innovative treatment approaches for microsatellite stable (MSS) tumors, which...
- Federal Grant Award Summary The National Cancer Institute awarded a $403,686 Project Grant to the University of California, Irvine under the Cancer Treatment Research program (CFDA 93.395) effective March 19, 2026, with a completion date of February 28, 2027. This research initiative will develop and validate a genetic screening approach to identify synergistic drug-diet interactions that enhance cancer therapy efficacy. The principal deliverables include the establishment of an unbiased,...
- Federal Grant Award Summary The National Cancer Institute (NCI), under its Cancer Treatment Research program (CFDA 93.395), awarded Weill Medical College of Cornell University a Project Grant of $606,839 effective June 1, 2025, through May 31, 2030. This research initiative investigates the role of gut microbiota amino acid metabolism in cancer development and progression. The award funds research designed to identify specific microbes and their genes that deplete intestinal amino acids and to...
- Federal Grant Award Summary The National Cancer Institute (NCI) awarded a $160,431 Project Grant under the Cancer Research Manpower program (CFDA 93.398) to the University of Tennessee Health Science Center, effective December 1, 2025. This F31 fellowship grant supports predoctoral research training focused on investigating the mechanistic relationship between gut microbiome modulation and breast cancer (BC) outcomes in the context of obesity and weight loss. The research aims to identify...
- Federal Grant Award Summary The National Cancer Institute (NCI) awarded the Regents of the University of Minnesota a $309,761 Project Grant under the Cancer Research Manpower program (CFDA 93.398) effective May 1, 2026, through April 30, 2031. The award funds development and delivery of an innovative training course in biomarker development and applications for cancer prevention research. The course combines virtual didactic modules on chemical carcinogenesis fundamentals with a five-week...